Sprout Social, Inc. <SPT.O>: Barclays Raises Target Price to $12 From $9
SPT•Related News
Shattuck Labs posts investor deck spotlighting DR3-blocking antibody SL-325 for inflammatory diseases
STTK•
Astrana Health, Inc. <ASTH.O>: Truist Securities raises target price to $55 from $47
ASTH•
Gain Therapeutics Q2 net loss per share narrows as R&D expenses fall
GANX•
Beyond Meat plunges after co announces 1-for-30 reverse stock split
BYND•
Barrick Mining <B.N>: Raymond James cuts target price to $56 from $58
B•